Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Depreciation and Depletion: 2020-2024

Historic Depreciation and Depletion for Immuneering (IMRX) over the last 5 years, with Dec 2024 value amounting to $355,807.

  • Immuneering's Depreciation and Depletion fell 4.05% to $86,116 in Q4 2024 from the same period last year, while for Dec 2024 it was $355,807, marking a year-over-year increase of 10.22%. This contributed to the annual value of $355,807 for FY2024, which is 10.22% up from last year.
  • As of FY2024, Immuneering's Depreciation and Depletion stood at $355,807, which was up 10.22% from $322,816 recorded in FY2023.
  • In the past 5 years, Immuneering's Depreciation and Depletion registered a high of $355,807 during FY2024, and its lowest value of $24,328 during FY2020.
  • For the 3-year period, Immuneering's Depreciation and Depletion averaged around $308,607, with its median value being $322,816 (2023).
  • Data for Immuneering's Depreciation and Depletion shows a peak YoY soared of 443.69% (in 2022) over the last 5 years.
  • Over the past 5 years, Immuneering's Depreciation and Depletion (Yearly) stood at $24,328 in 2020, then surged by 86.89% to $45,467 in 2021, then soared by 443.69% to $247,199 in 2022, then soared by 30.59% to $322,816 in 2023, then grew by 10.22% to $355,807 in 2024.